Sumitomo Pharma completed the acquisition of Nabriva Therapeutics.

Synopsis

Sumitomo Pharma, a pharmaceutical company based in Japan, completed the acquisition of Nabriva Therapeutics, a commercial-stage biopharmaceutical company. Financial terms were not disclosed.

Principals

target

Nabriva Therapeutics

bidder

Sumitomo Pharma

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers

Service Providers (2)

financial advisors

Stifel

legal advisors

Jones Day

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.